SK284600B6 - Farmaceutický prostriedok obsahujúci levosimendan - Google Patents

Farmaceutický prostriedok obsahujúci levosimendan Download PDF

Info

Publication number
SK284600B6
SK284600B6 SK1555-2000A SK15552000A SK284600B6 SK 284600 B6 SK284600 B6 SK 284600B6 SK 15552000 A SK15552000 A SK 15552000A SK 284600 B6 SK284600 B6 SK 284600B6
Authority
SK
Slovakia
Prior art keywords
levosimendan
composition
active ingredient
alginic acid
compositions
Prior art date
Application number
SK1555-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK15552000A3 (sk
Inventor
Ilkka Larma
Maarit B�Ckman
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of SK15552000A3 publication Critical patent/SK15552000A3/sk
Publication of SK284600B6 publication Critical patent/SK284600B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SK1555-2000A 1998-04-23 1999-04-23 Farmaceutický prostriedok obsahujúci levosimendan SK284600B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia
PCT/FI1999/000331 WO1999055337A1 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid

Publications (2)

Publication Number Publication Date
SK15552000A3 SK15552000A3 (sk) 2001-05-10
SK284600B6 true SK284600B6 (sk) 2005-07-01

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1555-2000A SK284600B6 (sk) 1998-04-23 1999-04-23 Farmaceutický prostriedok obsahujúci levosimendan

Country Status (33)

Country Link
US (1) US6531458B1 (ja)
EP (1) EP1079834B1 (ja)
JP (1) JP4475809B2 (ja)
KR (1) KR100590622B1 (ja)
CN (1) CN1165309C (ja)
AT (1) ATE231395T1 (ja)
AU (1) AU756338B2 (ja)
BG (1) BG64766B1 (ja)
BR (1) BR9909867A (ja)
CA (1) CA2329232C (ja)
CZ (1) CZ290911B6 (ja)
DE (1) DE69905034T2 (ja)
DK (1) DK1079834T3 (ja)
EA (1) EA002428B1 (ja)
EE (1) EE04143B1 (ja)
ES (1) ES2191426T3 (ja)
FI (1) FI980902A (ja)
GE (1) GEP20032942B (ja)
HK (1) HK1031998A1 (ja)
HR (1) HRP20000703B1 (ja)
HU (1) HUP0105446A3 (ja)
ID (1) ID26650A (ja)
IL (2) IL138950A0 (ja)
MX (1) MXPA00010368A (ja)
NO (1) NO318575B1 (ja)
NZ (1) NZ507455A (ja)
PL (1) PL192274B1 (ja)
PT (1) PT1079834E (ja)
RS (1) RS49955B (ja)
SK (1) SK284600B6 (ja)
TR (1) TR200003101T2 (ja)
WO (1) WO1999055337A1 (ja)
ZA (1) ZA200005630B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
EP1366761A4 (en) * 2001-02-13 2004-04-21 Taisho Pharmaceutical Co Ltd GEL PREPARATIONS FOR INTERNAL USE
EP1858518A1 (en) * 2005-03-14 2007-11-28 Orion Corporation A combination treatment for enhancing diuresis
CA3004362C (en) * 2015-11-06 2022-10-04 Carinopharm Gmbh Improved formulations of levosimendan for intravenous administration as infusion or injection and of infusion concentrate
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
PT76448B (en) * 1982-04-05 1986-03-20 Merck Sharp & Dohme Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
MXPA00010368A (es) 2002-07-02
PL192274B1 (pl) 2006-09-29
HUP0105446A3 (en) 2002-09-30
WO1999055337A1 (en) 1999-11-04
GEP20032942B (en) 2003-04-25
TR200003101T2 (tr) 2001-01-22
PT1079834E (pt) 2003-04-30
EA200001097A1 (ru) 2001-04-23
IL138950A0 (en) 2001-11-25
KR20010072577A (ko) 2001-07-31
NO318575B1 (no) 2005-04-11
DE69905034D1 (de) 2003-02-27
ES2191426T3 (es) 2003-09-01
CN1298303A (zh) 2001-06-06
US6531458B1 (en) 2003-03-11
NO20005312D0 (no) 2000-10-20
JP4475809B2 (ja) 2010-06-09
FI980902A0 (fi) 1998-04-23
HUP0105446A2 (hu) 2002-07-29
DK1079834T3 (da) 2003-04-07
YU64000A (sh) 2002-12-10
JP2002512964A (ja) 2002-05-08
KR100590622B1 (ko) 2006-06-19
EA002428B1 (ru) 2002-04-25
NZ507455A (en) 2002-02-01
BG104958A (en) 2001-07-31
HRP20000703B1 (en) 2009-11-30
EP1079834B1 (en) 2003-01-22
IL138950A (en) 2006-08-20
ID26650A (id) 2001-01-25
DE69905034T2 (de) 2003-09-04
ZA200005630B (en) 2002-01-14
BG64766B1 (bg) 2006-03-31
EE04143B1 (et) 2003-10-15
BR9909867A (pt) 2000-12-19
EE200000616A (et) 2002-06-17
EP1079834A1 (en) 2001-03-07
ATE231395T1 (de) 2003-02-15
CZ290911B6 (cs) 2002-11-13
RS49955B (sr) 2008-09-29
CZ20003779A3 (en) 2001-05-16
FI980902A (fi) 1999-10-24
NO20005312L (no) 2000-11-21
SK15552000A3 (sk) 2001-05-10
AU756338B2 (en) 2003-01-09
PL343722A1 (en) 2001-09-10
HRP20000703A2 (en) 2001-04-30
CA2329232A1 (en) 1999-11-04
AU3524899A (en) 1999-11-16
CA2329232C (en) 2007-10-30
HK1031998A1 (en) 2001-07-06
CN1165309C (zh) 2004-09-08

Similar Documents

Publication Publication Date Title
EP0305051B1 (en) Orally sustained-release acetaminophen formulation and process to obtain it
AU2003229705B2 (en) High drug load tablet
EP1035838B1 (en) Pharmaceutical suspension tablet compositions
IE880584L (en) Pharmaceutical tablet, pharmaceutical granulate and process¹for their preparation
JP2003530422A (ja) 医薬組成物
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
FI111519B (fi) Menetelmä sellaisen tabletin valmistamiseksi, joka sisältävää vaikuttavana aineena dikloorimetyleenifosfonihappoa
SK284600B6 (sk) Farmaceutický prostriedok obsahujúci levosimendan
JPH0678233B2 (ja) 抗高血圧症および心臓保護作用を有する医薬調剤
EP0319074B1 (en) Pharmaceutical composition and process for its preparation
US5183666A (en) Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing
JP3232687B2 (ja) イミダプリル含有製剤
AU2007201830B2 (en) High drug load tablet

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110423